Thrivent Financial for Lutherans
ABBV icon

Thrivent Financial for Lutherans’s AbbVie ABBV Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.7M Sell
228,616
-154,984
-40% -$34.4M 0.09% 267
2025
Q4 		$87.7M Sell
383,600
-37,698
-9% -$8.59M 0.16% 144
2025
Q3 		$97.5M Buy
421,298
+34,384
+9% +$7M 0.19% 115
2025
Q2 		$71.8M Buy
386,914
+125,719
+48% +$23.4M 0.16% 163
2025
Q1 		$53.5M Buy
261,195
+20,061
+8% +$3.9M 0.12% 226
2024
Q4 		$42.8M Sell
241,134
-91,118
-27% -$16.8M 0.08% 307
2024
Q3 		$65.6M Buy
332,252
+63,474
+24% +$11.8M 0.12% 229
2024
Q2 		$46.1M Sell
268,778
-59,129
-18% -$9.79M 0.09% 270
2024
Q1 		$59.7M Buy
327,907
+75,926
+30% +$13.1M 0.12% 229
2023
Q4 		$39M Sell
251,981
-18,999
-7% -$2.77M 0.09% 288
2023
Q3 		$40.5M Buy
270,980
+12,747
+5% +$1.87M 0.1% 269
2023
Q2 		$34.7M Buy
258,233
+109,722
+74% +$16.1M 0.08% 305
2023
Q1 		$23.6M Buy
148,511
+5,942
+4% +$908K 0.06% 381
2022
Q4 		$23.1M Buy
142,569
+383
+0.3% +$58.7K 0.06% 382
2022
Q3 		$19.4M Sell
142,186
-449,790
-76% -$64.5M 0.05% 398
2022
Q2 		$90.7M Sell
591,976
-146,079
-20% -$22.3M 0.24% 96
2022
Q1 		$119M Sell
738,055
-82,411
-10% -$12M 0.23% 103
2021
Q4 		$109M Buy
820,466
+86,144
+12% +$10.2M 0.21% 121
2021
Q3 		$79.3M Buy
734,322
+218,641
+42% +$25M 0.16% 163
2021
Q2 		$58.1M Buy
515,681
+39,859
+8% +$4.49M 0.12% 214
2021
Q1 		$51.5M Buy
475,822
+53,710
+13% +$5.74M 0.11% 214
2020
Q4 		$45.2M Buy
422,112
+239,319
+131% +$23M 0.1% 243
2020
Q3 		$16M Buy
182,793
+36,502
+25% +$3.44M 0.04% 455
2020
Q2 		$13.8M Buy
146,291
+14,062
+11% +$1.24M 0.04% 468
2020
Q1 		$10.1M Buy
132,229
+47,907
+57% +$4.08M 0.04% 499
2019
Q4 		$7.47M Buy
84,322
+2,127
+3% +$177K 0.02% 643
2019
Q3 		$6.22M Buy
82,195
+493
+0.6% +$33.8K 0.02% 632
2019
Q2 		$5.94M Buy
81,702
+1,236
+2% +$97.1K 0.02% 653
2019
Q1 		$6.49M Sell
80,466
-2,005
-2% -$164K 0.02% 603
2018
Q4 		$7.64M Buy
82,471
+1,168
+1% +$103K 0.03% 511
2018
Q3 		$7.69M Buy
81,303
+1,943
+2% +$184K 0.02% 548
2018
Q2 		$7.35M Buy
79,360
+1,795
+2% +$175K 0.02% 573
2018
Q1 		$7.34M Buy
77,565
+1,814
+2% +$199K 0.02% 550
2017
Q4 		$7.33M Buy
75,751
+763
+1% +$71.9K 0.02% 547
2017
Q3 		$6.66M Buy
74,988
+11,272
+18% +$858K 0.02% 545
2017
Q2 		$4.62M Buy
63,716
+1,661
+3% +$112K 0.02% 607
2017
Q1 		$4.04M Buy
62,055
+2,310
+4% +$145K 0.02% 645
2016
Q4 		$3.75M Buy
59,745
+1,682
+3% +$103K 0.02% 674
2016
Q3 		$3.66M Sell
58,063
-25,550
-31% -$1.65M 0.02% 692
2016
Q2 		$5.19M Buy
83,613
+2,662
+3% +$162K 0.02% 581
2016
Q1 		$4.63M Buy
80,951
+30,430
+60% +$1.7M 0.02% 626
2015
Q4 		$2.99M Buy
50,521
+5,171
+11% +$298K 0.01% 743
2015
Q3 		$2.47M Sell
45,350
-3,741
-8% -$244K 0.01% 740
2015
Q2 		$3.3M Sell
49,091
-6,100
-11% -$398K 0.02% 567
2015
Q1 		$3.23M Buy
55,191
+1,400
+3% +$84.6K 0.02% 583
2014
Q4 		$3.53M Sell
53,791
-43,169
-45% -$2.72M 0.02% 556
2014
Q3 		$5.6M Buy
96,960
+6,610
+7% +$367K 0.03% 428
2014
Q2 		$5.1M Buy
90,350
+53,050
+142% +$2.78M 0.03% 489
2014
Q1 		$1.92M Buy
37,300
+200
+0.5% +$10.1K 0.01% 606
2013
Q4 		$1.96M Buy
37,100
+300
+0.8% +$14.7K 0.01% 610
2013
Q3 		$1.65M Sell
36,800
-127,700
-78% -$5.66M 0.01% 619
2013
Q2 		$6.8K Buy
+164,500
New +$7.19M 0.04% 379

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Thrivent Financial for Lutherans's ABBV Position: Q1 2026 in Review

Thrivent Financial for Lutherans reduced its AbbVie (ABBV) stake by 40% in Q1 2026, selling an estimated $34.4M and leaving 228,616 shares worth $49.7M. The position accounts for 0.09% of the portfolio, ranked #267.

Thrivent Financial for Lutherans first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $119M in Q1 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Thrivent Financial for Lutherans held 228,616 shares of AbbVie worth $49.7M as of Q1 2026.
  • Thrivent Financial for Lutherans sold 154,984 AbbVie shares in Q1 2026, an estimated $34.4M.
  • AbbVie made up 0.09% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #267 holding.
  • Thrivent Financial for Lutherans first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Thrivent Financial for Lutherans's AbbVie position peaked at $119M in Q1 2022.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.